XML 55 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1

Supplemental Data (Tables)

6 Months Ended

Jun. 30, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Condensed Consolidating Statements of Income

Condensed Consolidating Statements of Income

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Three Months Ended June 30, 2017	DaVita Inc.
Patient services revenues	$	—			$	1,681,249			$	1,055,797			$	(54,579	)		$	2,682,467
Less: Provision for uncollectible accounts	—				(74,413		)		(41,072		)		—				(115,485		)
Net patient service revenues	—				1,606,836				1,014,725				(54,579		)		2,566,982
Capitated revenues	—				467,852				555,947				(1,721		)		1,022,078
Other revenues	193,585				501,861				34,257				(441,286		)		288,417
Total net revenues	193,585				2,576,549				1,604,929				(497,586		)		3,877,477
Operating expenses and charges	138,104				2,396,723				1,461,920				(497,586		)		3,499,161
Operating income	55,481				179,826				143,009				—				378,316
Debt expense	(106,159		)		(92,346		)		(14,943		)		105,486				(107,962		)
Other income, net	102,299				2,191				6,249				(105,486		)		5,253
Income tax expense	22,969				70,927				20,086				—				113,982
Equity earnings in subsidiaries	98,349				79,605				—				(177,954		)		—
Net income	127,001				98,349				114,229				(177,954		)		161,625
Less: Net income attributable to noncontrolling interests	—				—				—				(34,624		)		(34,624		)
Net income attributable to DaVita Inc.	$	127,001			$	98,349			$	114,229			$	(212,578	)		$	127,001

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Three Months Ended June 30, 2016	DaVita Inc.
Patient service revenues	$	—			$	1,664,361			$	959,946			$	(40,793	)		$	2,583,514
Less: Provision for uncollectible accounts	—				(74,498		)		(36,930		)		—				(111,428		)
Net patient service revenues	—				1,589,863				923,016				(40,793		)		2,472,086
Capitated revenues	—				463,732				436,337				(84		)		899,985
Other revenues	196,910				521,065				31,749				(404,144		)		345,580
Total net revenues	196,910				2,574,660				1,391,102				(445,021		)		3,717,651
Operating expenses	134,072				2,510,119				1,189,411				(445,021		)		3,388,581
Operating income	62,838				64,541				201,691				—				329,070
Debt expense	(102,101		)		(91,259		)		(12,998		)		103,464				(102,894		)
Other income	98,654				5,421				2,604				(103,464		)		3,215
Income tax expense	41,942				89,203				3,743				—				134,888
Equity earnings in subsidiaries	35,933				146,433				—				(182,366		)		—
Net income	53,382				35,933				187,554				(182,366		)		94,503
Less: Net income attributable to noncontrolling interests	—				—				—				(41,121		)		(41,121		)
Net income attributable to DaVita Inc.	$	53,382			$	35,933			$	187,554			$	(223,487	)		$	53,382

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2017	DaVita Inc.
Patient services revenues	$	—			$	3,234,605			$	2,154,549			$	(105,309	)		$	5,283,845
Less: Provision for uncollectible accounts	—				(136,694		)		(91,774		)		—				(228,468		)
Net patient service revenues	—				3,097,911				2,062,775				(105,309		)		5,055,377
Capitated revenues	—				931,479				1,010,901				(2,266		)		1,940,114
Other revenues	414,971				979,536				69,894				(885,132		)		579,269
Total net revenues	414,971				5,008,926				3,143,570				(992,707		)		7,574,760
Operating expenses and charges	270,014				4,276,878				2,754,023				(992,707		)		6,308,208
Operating income	144,957				732,048				389,547				—				1,266,552
Debt expense	(208,823		)		(183,747		)		(28,659		)		208,838				(212,391		)
Other income, net	202,636				5,728				9,970				(208,838		)		9,496
Income tax expense	57,062				292,348				52,337				—				401,747
Equity earnings in subsidiaries	492,990				231,309				—				(724,299		)		—
Net income	574,698				492,990				318,521				(724,299		)		661,910
Less: Net income attributable to noncontrolling interests	—				—				—				(87,212		)		(87,212		)
Net income attributable to DaVita Inc.	$	574,698			$	492,990			$	318,521			$	(811,511	)		$	574,698

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2016	DaVita Inc.
Patient services revenues	$	—			$	3,317,673			$	1,827,984			$	(80,209	)		$	5,065,448
Less: Provision for uncollectible accounts	—				(133,311		)		(87,322		)		—				(220,633		)
Net patient service revenues	—				3,184,362				1,740,662				(80,209		)		4,844,815
Capitated revenues	—				931,694				856,510				(211		)		1,787,993
Other revenues	383,885				1,005,420				59,269				(782,595		)		665,979
Total net revenues	383,885				5,121,476				2,656,441				(863,015		)		7,298,787
Operating expenses and charges	256,345				4,887,749				2,323,749				(863,015		)		6,604,828
Operating income	127,540				233,727				332,692				—				693,959
Debt expense	(203,202		)		(183,432		)		(24,512		)		205,368				(205,778		)
Other income, net	197,214				9,757				4,588				(205,368		)		6,191
Income tax expense	77,088				162,457				22,165				—				261,710
Equity earnings in subsidiaries	106,352				208,757				—				(315,109		)		—
Net income	150,816				106,352				290,603				(315,109		)		232,662
Less: Net income attributable to noncontrolling interests	—				—				—				(81,846		)		(81,846		)
Net income attributable to DaVita Inc.	$	150,816			$	106,352			$	290,603			$	(396,955	)		$	150,816

Condensed Consolidating Statements of Income

	Consolidated Total				Physician Groups				Unrestricted Subsidiaries				Company and Restricted Subsidiaries(1)
For The Six Months Ended June 30, 2017
Patient service operating revenues	$	5,283,845			$	273,017			$	—			$	5,010,828
Less: Provision for uncollectible accounts	(228,468		)		(7,351		)		—				(221,117		)
Net patient service operating revenues	5,055,377				265,666				—				4,789,711
Capitated revenues	1,940,114				785,139				—				1,154,975
Other revenues	579,269				19,596				—				559,673
Total net operating revenues	7,574,760				1,070,401				—				6,504,359
Operating expenses	6,308,208				1,032,529				(232		)		5,275,911
Operating income	1,266,552				37,872				232				1,228,448
Debt expense, including refinancing charges	(212,391		)		(3,323		)		—				(209,068		)
Other income	9,496				151				—				9,345
Income tax expense	401,747				32,700				93				368,954
Net income	661,910				2,000				139				659,771
Less: Net income attributable to noncontrolling interests	(87,212		)		—				—				(87,212		)
Net income attributable to DaVita Inc.	$	574,698			$	2,000			$	139			$	572,559

(1) After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Comprehensive Income

Condensed Consolidating Statements of Comprehensive Income

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Three Months Ended June 30, 2017	DaVita Inc.
Net income	$	127,001			$	98,349			$	114,229			$	(177,954	)		$	161,625
Other comprehensive income	436				—				49,142				—				49,578
Total comprehensive income	127,437				98,349				163,371				(177,954		)		211,203
Less: Comprehensive income attributable to    noncontrolling interest	—				—				—				(34,624		)		(34,624		)
Comprehensive income attributable to DaVita Inc.	$	127,437			$	98,349			$	163,371			$	(212,578	)		$	176,579

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Three Months Ended June 30, 2016	DaVita Inc.
Net income	$	53,382			$	35,933			$	187,554			$	(182,366	)		$	94,503
Other comprehensive loss	(1,530		)		—				(4,844		)		—				(6,374		)
Total comprehensive income	51,852				35,933				182,710				(182,366		)		88,129
Less: Comprehensive income attributable to the    noncontrolling interests	—				—				—				(41,270		)		(41,270		)
Comprehensive income attributable to DaVita Inc.	$	51,852			$	35,933			$	182,710			$	(223,636	)		$	46,859

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2017	DaVita Inc.
Net income	$	574,698			$	492,990			$	318,521			$	(724,299	)		$	661,910
Other comprehensive (loss) income	(70		)		—				62,403				—				62,333
Total comprehensive income	574,628				492,990				380,924				(724,299		)		724,243
Less: Comprehensive income attributable to    noncontrolling interest	—				—				—				(87,210		)		(87,210		)
Comprehensive income attributable to DaVita Inc.	$	574,628			$	492,990			$	380,924			$	(811,509	)		$	637,033

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2016	DaVita Inc.
Net income	$	150,816			$	106,352			$	290,603			$	(315,109	)		$	232,662
Other comprehensive (loss) income	(6,398		)		—				6,337				—				(61		)
Total comprehensive income	144,418				106,352				296,940				(315,109		)		232,601
Less: Comprehensive income attributable to the    noncontrolling interests	—				—				—				(81,995		)		(81,995		)
Comprehensive income attributable to DaVita Inc.	$	144,418			$	106,352			$	296,940			$	(397,104	)		$	150,606

Condensed Consolidating Statements of Comprehensive Income

	Consolidated Total				Physician Groups				Unrestricted Subsidiaries				Company and Restricted Subsidiaries(1)
For The Six Months Ended June 30, 2017
Net income	$	661,910			$	2,000			$	139			$	659,771
Other comprehensive income	62,333				—				—				62,333
Total comprehensive income	724,243				2,000				139				722,104
Less: Comprehensive income attributable to the noncontrolling    interests	(87,210		)		—				—				(87,210		)
Comprehensive income attributable to DaVita Inc.	$	637,033			$	2,000			$	139			$	634,894

(1) After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Balance Sheets

Condensed Consolidating Balance Sheets

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
As of June 30, 2017	DaVita Inc.
Cash and cash equivalents	$	374,973			$	40,508			$	296,516			$	—			$	711,997
Accounts receivable, net	—				1,278,053				775,759				—				2,053,812
Other current assets	254,108				891,208				112,643				—				1,257,959
Total current assets	629,081				2,209,769				1,184,918				—				4,023,768
Property and equipment, net	345,667				1,669,583				1,232,780				—				3,248,030
Intangible assets, net	355				1,405,712				56,827				—				1,462,894
Investments in subsidiaries	10,368,953				2,375,421				—				(12,744,374		)		—
Intercompany receivables	3,266,741				—				1,035,735				(4,302,476		)		—
Other long-term assets and investments	45,228				92,891				579,182				—				717,301
Goodwill	—				7,850,917				2,038,874				—				9,889,791
Total assets	$	14,656,025			$	15,604,293			$	6,128,316			$	(17,046,850	)		$	19,341,784
Current liabilities	$	399,436			$	1,807,277			$	566,612			$	—			$	2,773,325
Intercompany payables	—				2,181,952				2,120,524				(4,302,476		)		—
Long-term debt and other long-term liabilities	8,578,628				1,246,111				462,120				—				10,286,859
Noncontrolling interests subject to put provisions	593,647				—				—				416,057				1,009,704
Total DaVita Inc. shareholder's equity	5,084,314				10,368,953				2,375,421				(12,744,374		)		5,084,314
Noncontrolling interests not subject to put provisions	—				—				603,639				(416,057		)		187,582
Total equity	5,084,314				10,368,953				2,979,060				(13,160,431		)		5,271,896
Total liabilities and equity	$	14,656,025			$	15,604,293			$	6,128,316			$	(17,046,850	)		$	19,341,784

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
As of December 31, 2016	DaVita Inc.
Cash and cash equivalents	$	549,921			$	59,192			$	304,074			$	—			$	913,187
Accounts receivable, net	—				1,215,232				702,070				—				1,917,302
Other current assets	277,911				736,727				135,101				—				1,149,739
Total current assets	827,832				2,011,151				1,141,245				—				3,980,228
Property and equipment, net	337,200				1,689,798				1,148,369				—				3,175,367
Intangible assets, net	487				1,491,057				36,223				—				1,527,767
Investments in subsidiaries	9,717,728				2,002,660				—				(11,720,388		)		—
Intercompany receivables	3,250,692				—				866,955				(4,117,647		)		—
Other long-term assets and investments	39,994				86,710				523,874				—				650,578
Goodwill	—				7,838,984				1,568,333				—				9,407,317
Total assets	$	14,173,933			$	15,120,360			$	5,284,999			$	(15,838,035	)		$	18,741,257
Current liabilities	$	303,840			$	1,865,193			$	527,412			$	—			$	2,696,445
Intercompany payables	—				2,322,124				1,795,523				(4,117,647		)		—
Long-term debt and other long-term liabilities	8,614,445				1,215,315				392,053				—				10,221,813
Noncontrolling interests subject to put provisions	607,601				—				—				365,657				973,258
Total DaVita Inc. shareholder's equity	4,648,047				9,717,728				2,002,660				(11,720,388		)		4,648,047
Noncontrolling interests not subject to put provisions	—				—				567,351				(365,657		)		201,694
Total equity	4,648,047				9,717,728				2,570,011				(12,086,045		)		4,849,741
Total liabilities and equity	$	14,173,933			$	15,120,360			$	5,284,999			$	(15,838,035	)		$	18,741,257

Condensed Consolidating Balance Sheets

	Consolidated Total				Physician Groups				Unrestricted Subsidiaries				Company and Restricted Subsidiaries(1)
As of June 30, 2017
Cash and cash equivalents	$	711,997			$	107,232			$	—			$	604,765
Accounts receivable, net	2,053,812				213,804				—				1,840,008
Other current assets	1,257,959				13,679				—				1,244,280
Total current assets	4,023,768				334,715				—				3,689,053
Property and equipment, net	3,248,030				3,368				—				3,244,662
Amortizable intangibles, net	1,462,894				4,553				—				1,458,341
Other long-term assets	717,301				82,477				2,946				631,878
Goodwill	9,889,791				29,865				—				9,859,926
Total assets	$	19,341,784			$	454,978			$	2,946			$	18,883,860
Current liabilities	$	2,773,325			$	178,259			$	—			$	2,595,066
Payables to parent	—				114,038				2,946				(116,984		)
Long-term debt and other long-term liabilities	10,286,859				55,870				—				10,230,989
Noncontrolling interests subject to put provisions	1,009,704				—				—				1,009,704
Total DaVita Inc. shareholders’ equity	5,084,314				106,811				—				4,977,503
Noncontrolling interests not subject to put provisions	187,582				—				—				187,582
Shareholders’ equity	5,271,896				106,811				—				5,165,085
Total liabilities and shareholder’s equity	$	19,341,784			$	454,978			$	2,946			$	18,883,860

(1) After elimination of the unrestricted subsidiaries and the physician groups.

Condensed Consolidating Statements of Cash Flows

Condensed Consolidating Statements of Cash Flows

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2017	DaVita Inc.
Cash flows from operating activities:
Net income	$	574,698			$	492,990			$	318,521			$	(724,299	)		$	661,910
Changes in operating assets and liabilities and non-cash items included in net income	(431,980		)		52,218				4,997				724,299				349,534
Net cash provided by operating activities	142,718				545,208				323,518				—				1,011,444
Cash flows from investing activities:
Additions of property and equipment, net	(50,966		)		(182,494		)		(165,480		)		—				(398,940		)
Acquisitions	—				(538,450		)		(81,389		)		—				(619,839		)
Proceeds from asset and business sales	—				70,127				109				—				70,236
Proceeds (purchases) from investment sales and other items, net	49,036				(2,974		)		50,833				—				96,895
Net cash used in investing activities	(1,930		)		(653,791		)		(195,927		)		—				(851,648		)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(54,992		)		(6,893		)		(2,147		)		—				(64,032		)
Intercompany (payments) borrowing	(37,233		)		98,224				(60,991		)		—				—
Other items	(223,511		)		(1,432		)		(76,203		)		—				(301,146		)
Net cash (used in) provided by financing activities	(315,736		)		89,899				(139,341		)		—				(365,178		)
Effect of exchange rate changes on cash	—				—				4,192				—				4,192
Net decrease in cash and cash equivalents	(174,948		)		(18,684		)		(7,558		)		—				(201,190		)
Cash and cash equivalents at beginning of period	549,921				59,192				304,074				—				913,187
Cash and cash equivalents at end of period	$	374,973			$	40,508			$	296,516			$	—			$	711,997

					Guarantor subsidiaries				Non- Guarantor subsidiaries				Consolidating adjustments				Consolidated total
For The Six Months Ended June 30, 2016	DaVita Inc.
Cash flows from operating activities:
Net income	$	150,816			$	106,352			$	290,603			$	(315,109	)		$	232,662
Changes in operating assets and liabilities and non-cash    items included in net income	(1,505		)		219,697				179,676				315,109				712,977
Net cash provided by operating activities	149,311				326,049				470,279				—				945,639
Cash flows from investing activities:
Additions of property and equipment, net	(42,266		)		(171,164		)		(145,197		)		—				(358,627		)
Acquisitions	—				(462,592		)		(10,722		)		—				(473,314		)
Proceeds from asset and business sales	—				17,393				—				—				17,393
Proceeds (purchases) from investment sales and other    items, net	21,230				(10,869		)		45,958				—				56,319
Net cash used in investing activities	(21,036		)		(627,232		)		(109,961		)		—				(758,229		)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(42,493		)		(13,917		)		(4,823		)		—				(61,233		)
Intercompany borrowing (payments)	11,208				247,765				(258,973		)		—				—
Other items	(255,032		)		(6,253		)		(81,036		)		—				(342,321		)
Net cash (used in) provided by financing activities	(286,317		)		227,595				(344,832		)		—				(403,554		)
Effect of exchange rate changes on cash	—				—				444				—				444
Net (decrease) increase in cash and cash equivalents	(158,042		)		(73,588		)		15,930				—				(215,700		)
Cash and cash equivalents at beginning of period	1,186,636				109,357				203,123				—				1,499,116
Cash and cash equivalents at end of period	$	1,028,594			$	35,769			$	219,053			$	—			$	1,283,416

Condensed Consolidating Statements of Cash Flows

	Consolidated Total				Physician Groups				Unrestricted Subsidiaries				Company and Restricted Subsidiaries(1)
For The Six Months Ended June 30, 2017
Cash flows from operating activities:
Net income	$	661,910			$	2,000			$	139			$	659,771
Changes in operating and intercompany assets and liabilities    and non-cash items included in net income	349,534				(37,812		)		(139		)		387,485
Net cash provided by (used in) operating activities	1,011,444				(35,812		)		—				1,047,256
Cash flows from investing activities:
Additions of property and equipment	(398,940		)		(5,603		)		—				(393,337		)
Acquisitions and divestitures, net	(619,839		)		—				—				(619,839		)
Proceeds from discontinued operations	70,236				—				—				70,236
Investments and other items	96,895				(1,386		)		—				98,281
Net cash used in investing activities	(851,648		)		(6,989		)		—				(844,659		)
Cash flows from financing activities:
Long-term debt	(64,032		)		—				—				(64,032		)
Intercompany	—				45,342				—				(45,342		)
Other items	(301,146		)		—				—				(301,146		)
Net cash (used in) provided by financing activities	(365,178		)		45,342				—				(410,520		)
Effect of exchange rate changes on cash	4,192				—				—				4,192
Net (decrease) increase in cash	(201,190		)		2,541				—				(203,731		)
Cash and cash equivalents at beginning of period	913,187				104,691				—				808,496
Cash and cash equivalents at end of period	$	711,997			$	107,232			$	—			$	604,765

(1) After elimination of the unrestricted subsidiaries and the physician groups.

X

- Definition

Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.

+ References

No definition available.

+ Details

Name:	us-gaap_CondensedStatementOfComprehensiveIncomeTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of condensed cash flow statement, including, but not limited to, cash flow statements of consolidated entities and consolidation eliminations.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCondensedCashFlowStatementTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration